68-4

106/136

426 120) Soeda T, Okura H, Saito Y, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M: J-MINUET investigators. Clin-ical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infaction-J-MINUET study. J Cardiol, 2020; S0914-5087: 30291-4. 121) Yamamoto K, Natsuaki M, Yoshikawa Y, Morimoto T, Shiomi H, Watanabe H, Kato T, Saito N, Kadota K, Ando K, Furukawa Y, Tamura T, Sakamoto H, Toyofuku M, Inada T, Inoko M, Suwa S, Onodera T, Ishii K, Kanamori N, Kimura T: CREDO-Kyoto PCI/CABG Registry Cohort-Investigators. Effect of body weight on bleeding and ischemic events in patients undergoing percutaneous coronary intervention-from the CREDO-Kyoto Registry Cohort-2. Circ J, 2020; 84: 1734-1745. 122) Watanabe H, Morimoto T, Ogita M, Suwa S, Natsuaki M, Suematsu N, Koeda Y, Morino Y, Nikaido A, Hata Y, doi M, Hibi K, Kimura K, Yoda S, Kaneko T, Nishida K, Kazai K, Yama-guchi K, Wakatsuki T, Tonoike N, Yamamoto M, Shimizu S, Shimohama T, Ako J, Kimura T*, on behalf of STOPDAPT-2 investigators: Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clin-ical outcomes after percutaneous coronary intervention; A genetic substudy from the STOPDAPT-2. Cardiovasc Interv Ther, 2020. (Online ahead of print). 123) Horie K, Kuramitsu S, Matsuo H, Shinozaki T, Takashima H, Shiono Y, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Asano T, Tsujita K, Masamura K, Doijiri T, Ogita M, Kurita T, Matsuo A, Sonoda S, Yokoi H, Tanaka N, on behalf of J-CONFIRM investi-gators: Two-year outcomes of asymptomatic versus symptomatic patients after deferral of revascularization based on fractional flow reserve: Insights from the J-CONFIRM registry. Circulation Reports. 2020. (Online ahead of print). 124) Kimura T, Akahori H, Asakura M, Nakano K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M: J-MINUET investi-gators. Impact of age on gender difference in long-term outcomes of patients with acute myocardial infaction (From J-MINUET) Am J Cardiol, 2020; S0002-9149: 31304-7. 125) Natsuaki M, Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, Tada T, Suwa S, Kaneda K, Watanabe H, Tazaki J, Watanabe S, Yamamoto E, Saito N, Fuki M, Takeda T, Eizawa H, Shinoda E, Mabuchi H, Shirotani M, Uegaito T, Matsuda M, Takahashi M, Inoko M, Tamura T, Ishii K, Onodera T, Sakamoto H, Aoyama T, Sato Y, Ando K, Frukawa Y, Nakagawa Y, Kadota K, Kimura T*; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investi-gators: Application of the modified high bleeding risk criteria for Japanese patients in an all-comers registry of percutaneous coro-nary intervention-from the CREDO-Kyoto Registry Cohort-3. Circ J, 2020.doi;10.1253/circj.CJ-20-036. Online ahead of print. 126) Wada H, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M: J-MINUET investiga-tors. Prediction of long-term outcomes in ST-elevation myocardial infarction and non- ST segment myocardial infarction with and without creatinine kinase elevation-post-hoc analysis of the J-MINUET study. Int Heart J, 2020 (In Press). 127) Nishio R, Ogita M, Wada H, Nozaki Y, Taka-